WHO dystopia
A warning about a potential dystopian future from Mr Philipp Kruse, international lawyer, based in Zurick, Switzerland.
41.8K
views
182
comments
WHO threat
Health and Democracy Conference 13 September, 2023 EU Parliament Strasbourg
Philipp Kruse one of the lawyers involved in citizens initiative gives a speech at the European Parliament for the ECI citizens initiative to challenge the WHO on their pandemic treaty.
The Powergrab of the World Health Organisation (WHO) Philipp Kruse
https://www.youtube.com/watch?v=PQ86dgzduVU
https://apps.who.int/gb/wgihr/pdf_files/wgihr1/WGIHR_Compilation-en.pdf
https://www.consilium.europa.eu/en/po... https://apps.who.int/gb/wgpr/pdf_file...
Philipp Kruse
https://www.youtube.com/watch?v=07gX9IFqNRM
49.7K
views
264
comments
Viral origins and scientific dystopia
Professor Angus Dalgleish
The Origin of the Virus: The hidden truths behind the microbe that killed millions of people
https://www.amazon.co.uk/Origin-Virus-hidden-microbe-millions/dp/1854571060/ref=sr_1_1?crid=2CLT7DF6A3HCQ&keywords=the+origin+of+the+virus&qid=1696971118&sprefix=the+origin+of+the+virus%2Caps%2C90&sr=8-1
The Real Anthony Fauci: Bill Gates, Big Pharma, and the Global War on Democracy and Public Health
https://www.amazon.co.uk/Real-Anthony-Fauci-Pharma-Democracy/dp/B09LVY1WHB/ref=sr_1_1?crid=15763ETGUTIHY&keywords=the+real+anthony+fauci+by+robert+f.+kennedy+jr&qid=1696971240&sprefix=the+real+anthony+fau%2Caps%2C89&sr=8-1
Viral: The Search for the Origin of Covid-19 https://www.amazon.co.uk/Audible-Viral-Search-Origin-Covid-19/dp/B09FN832VM/ref=sr_1_1?crid=28Y55QQGIW5DP&keywords=viral&qid=1696971371&s=audible&sprefix=viral%2Caudible%2C78&sr=1-1
Mycobacteria, Gramm positive, rod shaped, TB, leprosy
(mould like colony surfaces)
Viral ‘inserts’
Not naturally occurring
Similar to those published from Wuhan lab
Single epidemiological outbreak, one place one time
Similarity to viruses from North Thailand area
No animal vector identified
Wuhan database taken off line late 2019
Wuhan biosafety events
No antibody evidence from previous infections in humans or animals
Homologous sequences with HI Virus
Furin cleavage site in the spike protein
Furin is a human transmembrane protein
794 amino acids
Natural, accidental, or deliberate
https://www.help.senate.gov/imo/media/doc/report_an_analysis_of_the_origins_of_covid-19_102722.pdf
https://foreignaffairs.house.gov/wp-content/uploads/2020/09/Final-Minority-Report-on-the-Origins-of-the-COVID-19-Global-Pandemic-Including-the-Roles-of-the-CCP-and-WHO-9.20.20-Coverpage.pdf
https://www.nejm.org/doi/full/10.1056/NEJMp2305081
33.8K
views
97
comments
I want this new vaccine
Profound new medical research from Professor Angus Dalgleish, MD, FRCP, FRCPA, FRCPath, FMedSci
Clinical consultant treating melanoma
Heat killed mycobacteria to boost immune system, INM101
29.7K
views
67
comments
VAERS data with Dr. Jessica Rose
Links for Jessica
https://jessicasuniverse.com
https://jessicar.substack.com
https://jessica5b3.substack.com
@JessLovesMJK
30.7K
views
39
comments
Cancer reactivation
Professor Angus Dalgleish, MD, FRCP, FRCPA, FRCPath, FMedSci
Clinical consultant treating melanoma
Heat killed mycobacteria to boost immune system, INM101
Endemic vitamin D in the UK, if this is improved, immunotherapy also improves.
5 – 20 year stable melanoma patient relapsing
Melanomas often activated after extreme stress, divorce, bereavement etc.
Now seeing more melanoma relapse, but these patients did not have life trauma, but they had been boosted.
In the group getting melanoma relapses, they all mentioned they were up to date with covid boosters.
Could it be the boosters that were leading to the relapse.
After 30 years of vaccine work and research, focus on antibodies is misguided, T cells are more important.
Innate T cell activity goes down after age of 55, in your boots by age 70
As innate T cell function goes down cancers increase
So, does the decline in innate T cell activity causse’ the increase in cancer
Heat killed mycobacterial vaccine boosts this immune response.
If you keep giving killed mycobacterium, it does not induce antibodies, just keeps boosting T cells.
Also seems to protect against colds and flu by boosting immune response.
PD predicted this would be a good front line for covid.
At the height of the first wave, none of the patients on mycobacteria vaccine caught covid, eval although they had advanced melanoma. Staff were getting ill, none of the vulnerable patients got sick with covid.
In general, if you need to give more than 2 shots of vaccine, it doesn’t work.
Vaccines should be given to people with known immune status.
If you don’t need a vaccine it will make things worse.
You only have a limited capacity in your immune system.
If you boost with another vaccine, to harness half of the immune system to make antibodies, to a virus, which no longer exists on the planet.
Then you will weaken the immune system.
Confirmed by science, after booster you no longer make IgG 1 and 3 neutralising antibodies, you make IgG4
Boosters also suppress the T cell response.
T cell response crashes after the booster in cancer patients, not in all but many of these patients.
T cells control melanoma, relapses only occurred when there was T cell perturbation. Boosters cause perturbation. (First 11 minutes)
60.5K
views
153
comments
Explosive cancers
Professor Angus Dalgleish is seeing reactivations of stable cancers after covid vaccination
49.8K
views
107
comments
Pfizer vaccine manufacture
Two different manafacturing processes. Pfizer covid vaccines for the clinical trials were mostly produced using manufacturing ‘process 1’ whereas the vaccines used for population vaccination were produced using a different ‘process 2’
Interview with Josh Guetzkow PhD
Here is the BMJ link: https://www.bmj.com/content/378/bmj.o1731/rr-2
Josh's handle on X.com is @joshg99 and here is a link to a thread I did on P1 vs. P2: https://x.com/joshg99/status/1658421192326365185
Here is a link to my blog:
https://researchrebel.substack.com/
Here are links to my posts on the Pfizer clinical trial
https://researchrebel.substack.com/p/comirnaty-or-comirnaughty
https://researchrebel.substack.com/p/how-long-did-the-pfizer-covid-vaccine
https://researchrebel.substack.com/p/the-pfizer-vaccine-trial-was-not
https://www.bmj.com/content/378/bmj.o1731/rr-2
https://www.nejm.org/doi/suppl/10.1056/NEJMoa2034577/suppl_file/nejmoa2034577_protocol.pdf
https://twitter.com/joshg99/status/1658421192326365185
https://phmpt.org/wp-content/uploads/2023/04/125742_S1_M5_5351_c4591001-interim-mth6-report-body.pdf
36.3K
views
102
comments
Pfizer, manufacturing process changed
Here is the BMJ link: https://www.bmj.com/content/378/bmj.o1731/rr-2
X.com is @joshg99 and here is a link to a thread I did on P1 vs. P2: https://x.com/joshg99/status/1658421192326365185
Here is a link to my blog:
https://researchrebel.substack.com/
Here are links to my posts on the Pfizer clinical trial
https://researchrebel.substack.com/p/comirnaty-or-comirnaughty
https://researchrebel.substack.com/p/how-long-did-the-pfizer-covid-vaccine
https://researchrebel.substack.com/p/the-pfizer-vaccine-trial-was-not
23.5K
views
46
comments
Lockdown evidence weak
Evidence for non-pharmaceutical interventions such as mass lockdowns was weak. Not that you could have guessed that easily at the time from government messaging.
Research and analysis
COVID-19: non-pharmaceutical interventions to reduce transmission
https://www.gov.uk/government/publications/covid-19-non-pharmaceutical-interventions-to-reduce-transmission
28 September 2023
Identify and categorise primary studies that reported on the effectiveness of non-pharmaceutical interventions (NPIs),
implemented in community settings to reduce the transmission of coronavirus (COVID-19) in the UK.
Physical distancing
Surface cleaning
Face coverings
Hand and respiratory hygiene
Ventilation
Measures to identify and isolate those who are infectious or may become infectious,
such as testing and isolation (also known as quarantine)
Measures to reduce the number of contacts,
including lockdown,
settings closures and limitation of social contacts (such as the ‘rule of 6’)
Shielding of the most clinically vulnerable
Travel and border restrictions
Review includes 151 studies (search date: 1 March 2023)
Evidence gap map for NPIs
https://research.ukhsa.gov.uk/evidence-gap-map-npi-and-covid-19/
Only 19 of the 151 studies reported on effectiveness of measures to reduce infection risk at individual level,
of which 14 reported on face coverings.
This suggests that there is an evidence gap for other measures within this category,
such as hand and respiratory hygiene,
ventilation and cleaning
(studies that reported on packages of NPIs were excluded).
Two-thirds of the evidence identified was based on modelling studies (100 out of 151 studies).
There was a lack of experimental studies (2 out of 151 studies)
Individual-level observational studies (22 out of 151 studies).
On measures aimed to reduce infection risk at individual level
The evidence available for this category is therefore likely to be weak, both in terms of study design and potential bias.
Studies reporting on travel and border restrictions
a weak evidence base in terms of study design.
Apart from test and release strategies for which 2 randomised controlled trials (RCTs) were identified,
the body of evidence available on effectiveness of NPIs in the UK provides weak evidence in terms of study design,
as it is mainly based on modelling studies,
ecological studies, (relationship between outcome and exposure at a population level)
mixed-methods studies and qualitative studies.
For future pandemic preparedness
A need to strengthen evaluation of interventions,
and build this into the design and implementation of public health interventions,
and government policies from the start of any future pandemic,
or other public health emergency.
The next steps are to critically appraise and synthesise the evidence identified on the effectiveness of individual NPIs,
implemented in community settings to reduce the transmission of COVID-19 in the UK.
There is also a need to review and assess the evidence on the economic impact of NPIs,
as well as their wider impact, including on mental health and health inequalities.
For future reports
More on harm / benefit analysis
30.1K
views
145
comments
UK parliament to debate excess deaths
BUT, I suspect very few will turn up. Why will MPs not attent this essential debate???????????????
https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsregisteredweeklyinenglandandwalesprovisional/weekending15septemner2023
Week ending 15 September 2023 (Week 37)
Deaths registered in the UK was 11,688, which was 2.9% above the five-year average (330 excess deaths)
https://app.powerbi.com/view?r=eyJrIjoiYmUwNmFhMjYtNGZhYS00NDk2LWFlMTAtOTg0OGNhNmFiNGM0IiwidCI6ImVlNGUxNDk5LTRhMzUtNGIyZS1hZDQ3LTVmM2NmOWRlODY2NiIsImMiOjh9
https://ourworldindata.org/grapher/excess-mortality-p-scores-average-baseline
https://stats.oecd.org/index.aspx?queryid=104676
UK, + 36,316
Hungary, - 3,183
USA, 147,828
Poland, - 456
Australia, + 9,992
Canada, + 3,954
Netherlands, + 9,002
New Zealand, + 2,804
Sweden, - 1,082
Denmark, + 1,895
54.7K
views
242
comments
Multicultural health
Discussion about multicultural aspect of health care.
The Liger, Rex Soderlund
https://theliger.substack.com/p/understanding-ecological-technology
Wefwafwa’s channel
https://www.youtube.com/@WefwafwaAndrew
32.2K
views
20
comments
Sinister WHO plans
if you are a citizen or resident of the UK, please sign this petition and spread the word. The deadline to sign is October 3, 2023.
https://petition.parliament.uk/petitions/635904
https://jamesroguski.substack.com/p/an-open-letter-to-world-leaders
http://StopTheAmendments.com
http://ExitTheWHO.org (worldwide)
http://ExitTheWHO.com (USA)
http://ThePeoplesDeclaration.com
http://ScrewTheWHO.com
http://JamesRoguski.substack.com/archive
+1 310-619-3055 (yes - feel free to include my number)
Sincerely,
James Roguski
40.9K
views
115
comments
Data confirms excess deaths in 2023
Confirmation of excess deaths in 2023 for US, UK, Canada, Australia, NZ, Netherlands, and Denmark. However, deaths are lower than expected in Poland, Hungary, and Sweden.
OECD data
https://stats.oecd.org/index.aspx?queryid=104676
58.4K
views
236
comments
vacine mRNA in breast milk
Biodistribution of mRNA COVID-19 vaccines in human breast milk
https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(23)00366-3/fulltext
Background
Several vulnerable groups, such as pregnant and lactating women, have been excluded from the initial vaccine clinical trials.
The possible passage of the vaccine mRNA to breast milk (BM), resulting in neonatal exposure, was not investigated.
As a result, limited research has been conducted on the systemic distribution of vaccine mRNA during lactation,
and whether it is excreted in human breast milk (BM).
We evaluated if COVID-19 vaccine mRNA is detectable in breast milk after maternal vaccination,
and determined its potential translational activity.
Methods
We collected breast milk samples from 13 lactating, healthy, post-partum women before and after COVID-19 mRNA vaccination.
Vaccine mRNA in whole breast milk and BM extracellular vesicles (EVs) assayed using quantitative Droplet Digital PCR,
and its integrity and translational activity were evaluated.
Findings
Of 13 lactating women receiving the vaccine (20 exposures),
trace mRNA amounts were detected in 10 exposures,
up to 45 hours post-vaccination.
The mRNA was concentrated in the breast milk extracellular vesicles (EVs);
This can be significant as the breast milk extracellular vesicles act as natural LNPs, protecting the mRNA from degradation.
Milk-derived EVs are resistant to proteolysis by gastric and pancreatic secretions and can be readily absorbed by intestinal epithelial cells
However, these EVs neither expressed SARS-COV-2 spike protein,
nor induced its expression in the HT-29 cell line.
However, positive control samples used in concentrations similar to those of BM EVs also failed to induce S protein expression.
Vaccine mRNA integrity was reduced to 12–25% in BM.
Interpretation
Our findings demonstrate that the COVID-19 vaccine mRNA is not confined to the injection site,
but spreads systemically and is packaged into BM EVs.
We believe breastfeeding post-vaccination is safe, especially 48 h after vaccination.
Further investigation is required to determine the minimum amount of mRNA needed to elicit an immune response in newborns
Nevertheless, since the minimum mRNA vaccine dose to elicit an immune reaction in infants <6 months is unknown,
a dialogue between a breastfeeding mother and her healthcare provider should address the benefit/risk considerations of breastfeeding in the first two days after maternal vaccination.
Funding
Department of Pediatrics, NYU-Grossman Long Island School of Medicine.
More detail
The mRNA COVID-19 vaccines comprise lipid nanoparticles (LNPs) that contain mRNA coding the SARS-CoV-2 S protein as the active component.
Relatively little has been reported on the tissue localization of the LNPs after intramuscular administration of the vaccine.
Following intramuscular administration, the vaccine LNPs were rapidly disseminated to several organs
Potential translational activity were not evaluated.
53.8K
views
227
comments
Vaccine reactions made transparent
The OpenVAERS Project allows browsing and searching of the VAERS reports
https://vaers.hhs.gov
https://vaers.hhs.gov/docs/VAERSDataUseGuide_November2020.pdf
https://openvaers.com
https://www.openvaers.com/covid-data
Guide to Interpreting VAERS Data
https://vaers.hhs.gov/data/dataguide.html
"Underreporting" is one of the main limitations of passive surveillance systems,
including VAERS.
VAERS receives reports for only a small fraction of actual adverse events.
Electronic Support for Public Health–Vaccine Adverse Event Reporting System (ESP:VAERS)
https://digital.ahrq.gov/sites/default/files/docs/publication/r18hs017045-lazarus-final-report-2011.pdf
Less than 0.3% of all adverse drug events,
and 1-13% of serious events are reported to the Food and Drug
Administration (FDA).
Likewise, fewer than 1% of vaccine adverse events are reported.
I would add
Essentially only shows temporal correlations
Covid vaccines in comparison with traditional vaccines and other common drugs
https://docs.google.com/document/d/1KuV9FMkdCZ1hr50J_tvaIwArZnVuHNMUoVXQ1hhub68/edit?pli=1#heading=h.plbt52rt9rop
https://worldcouncilforhealth.org/resources/covid-19-vaccine-pharmacovigilance-report/
https://who-umc.org/vigibase/vigibase-services/
41.1K
views
116
comments
Canada, the people speak
Canadian National Citizens Inquiry (interim report)
Discussion with Mr Ches Crosbie, National Citizens Inquiry administrator.
Check out the full report on this link
https://nationalcitizensinquiry.ca/commissioners-report/
Surely it is the job of governments to evaluate the nature of the national response to the covid pandemic?
Why have a group of concerned Canadian citizens felt it necessary to make this enquiry and evaluation?
How were the covid vaccines first authorised in Canada?
Its over 2 and a half years later, have the covid vaccines not been approved under the traditional approval process for drugs in Canada?
Is NCI now satisfied that Health Canada has now establish the safety and efficacy of Covid-19 vaccines?
Has HC published transparent strict proof of safety and efficacy of covid vaccines as it has worked through the established Canadian drug approval regulations?
What is the system for reporting adverse vaccine reactions in Canada?
Is this system functional, universally known and easy to use,
does it publish full objective data for individuals to make a vaccination decision based on full informed consent?
https://www.canada.ca/en/public-health/services/diseases/coronavirus-disease-covid-19.html
27.3K
views
95
comments
Activated vitamin D
Free download John’s textbooks in high res pdf.
https://drjohncampbell.co.uk
Order my Physiology Notes in hard copy if you live in the UK,
https://www.ebay.co.uk/itm/154973392319?mkcid=16&mkevt=1&mkrid=711-127632-2357-0&ssspo=K6raxMZrQnm&sssrc=2047675&ssuid=&widget_ver=artemis&media=EMAIL
36K
views
105
comments
More covid jabs for all in the US
Updated COVID-19 vaccines are recommended for everyone 6 months and older and will be available by the end of this week
‘Safe and effective’
Estimated hospitalizations prevented per 1,000,000 vaccine doses
12 -17 years
19-95 hospitalizations,
5-19 ICU admissions,
and perhaps one death.
5 – 11 years
16 hospitalizations,
(based on Spring 2023 data)
18 – 49 years
75 hospitalizations,
(based on Spring 2023 data)
Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults
https://pubmed.ncbi.nlm.nih.gov/36055877/
Pfizer vaccines excess risk of serious adverse events
(Higher than placebo baseline)
10.1 per 10,000
101 per 100,000
1,010 per 1,000,000
Moderna vaccines excess risk of serious adverse events
(Higher than placebo baseline)
15.1 per 10,000
151 per 100,000
1,510 per 1,000,000
In Western Australia
https://www.health.wa.gov.au/~/media/Corp/Documents/Health-for/Immunisation/Western-Australia-Vaccine-Safety-Surveillance-Annual-Report-2021.pdf
Total AEFI rate following a COVID-19 vaccine
264.1 per 100,000 doses
2,641 per 1,000,000 doses
https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-ceo-bancel-defends-130-covid-vaccine-price-senate-hearing-2023-03-22/
March 22 Moderna chief executive defended the company's plan to quadruple the price of its COVID-19 vaccine,
$130 per dose
Pfizer last year suggested $110 to $130 per dose.
From FDA to MHRA: are drug regulators for hire?
https://www.bmj.com/content/377/bmj.o1538
Money derived from Industry
US Food and Drug Administration, $3,416,000,000 (2022)
The revolving door
FDA, nine out of 10 of its past commissioners, 2006 to 2019 went on to secure roles linked with pharmaceutical companies
https://www.fda.gov/about-fda/fda-organization/robert-califf
2005 UK, House of Commons’ health committee
Industry funding could lead MHRA, to “lose sight of the need to protect and promote public health above all else as it seeks to win fee income from the companies.”
BMJ investigation (2022)
We found that industry money permeates the globe’s leading regulators,
raising questions about their independence
Sociologist Donald Light, Rowan University, New Jersey
“Like the FDA, the TGA was founded to be an independent institute.
However, being largely funded by fees from the companies whose products it is charged to evaluate is a fundamental conflict of interest,
and a prime example of institutional corruption.”
It is no longer possible for doctors and patients to receive unbiased, rigorous evaluations from drug regulators.
FDA
“It’s the opposite of having a trustworthy organisation independently and rigorously assessing medicines.
They’re not rigorous, they’re not independent, they are selective, and they withhold data.
Doctors and patients must appreciate how deeply and extensively drug regulators can’t be trusted so long as they are captured by industry funding.”
Revisiting financial conflicts of interest in FDA advisory committees
https://pubmed.ncbi.nlm.nih.gov/25199895/
Large study, FDA advisory committee members over 15 years,
those with financial interests solely in the sponsoring firm were more likely to vote in favour of the sponsor’s product.
36.9K
views
199
comments
The Nuremberg Code
Nuremberg Code (1947)
https://research.unc.edu/human-research-ethics/resources/ccm3_019064/
https://encyclopedia.ushmm.org/content/en/article/the-nuremberg-code
https://encyclopedia.ushmm.org/content/en/article/nazi-medical-experiments
Medical Case: US prosecutor details illegal experiments
In case you want to support our community work use the following:
https://www.justgiving.com/crowdfunding/buwanga-mill?utm_term=gmbP2vbY3
https://www.buymeacoffee.com/awmedicalvideos
patreon:https://www.patreon.com/awmedicalvideos
Link to our organization's website:
https://buwanga.org/
Donate: SENDWAVE/ WorldRemit / Wise transfer/Money Gram
Mobile money number:+256785698803
Country: Uganda
Registered name: Wefwafwa Andrew
State: Eastern Uganda
Address: Nkokojjeru
Zip code:0000
Wallet Service provider:MTNE
To contact Wefwafwa directly, wefandrew@gmail.com or
WhatsApp+256756320736
Medical professionals on trial, after war for war crimes and crimes against humanity
Including experiments on prisoners in the camp system.
Doctors and nurses, participated in the killing of physically and mentally impaired Germans
German doctors argued
"Doctors Trial." 1946
Trials of War Criminals before the Nuremberg Military Tribunals under Control Council Law No. 10. Nuremberg October 1946 – April 1949
Their experiments differed little from those conducted before the war by German and American scientists.
No international law or informal statement differentiated between legal and illegal human experimentation.
“Permissible Medical Experiments.”
Washington. U.S. Government Printing Office (n.d.), vol. 2., pp. 181-182.
One
The voluntary consent of the human subject is absolutely essential.
This means that the person involved should have legal capacity to give consent;
should be situated as to be able to exercise free power of choice,
without the intervention of any element of force, fraud, deceit, duress, over-reaching, or other ulterior form of constraint or coercion,
and should have sufficient knowledge and comprehension of the elements of the subject matter involved as to enable him to make an understanding and enlightened decision.
Before the acceptance of an affirmative decision,
subject should know the nature, duration, and purpose of the experiment;
the method and means by which it is to be conducted;
all inconveniences and hazards reasonably to be expected;
and the effects upon his health or person which may possibly come from his participation in the experiment.
The duty and responsibility for ascertaining the quality of the consent rests upon each individual who initiates, directs or engages in the experiment.
It is a personal duty and responsibility which may not be delegated to another with impunity.
Two
The experiment should yield fruitful results for the good of society,
unprocurable by other methods,
and not random and unnecessary in nature.
Three
The experiment should be based on the results of animal experimentation,
a knowledge of the natural history of the disease or other problem,
the anticipated results will justify the performance of the experiment.
Four
The experiment should avoid all unnecessary physical and mental suffering and injury.
Five
No experiment should be conducted where there is an a priori reason to believe that death or disabling injury will occur;
except, perhaps, in those experiments where the experimental physicians also serve as subjects.
Six
The degree of risk should never exceed,
that determined by the humanitarian importance,
of the problem to be solved by the experiment.
Seven
Proper preparations should be made,
and adequate facilities provided,
to protect the experimental subject against even remote possibilities of injury disability or death.
Eight
The experiment should be conducted only by scientifically qualified persons.
The highest degree of skill and care should be required through all stages of the experiment
Nine
During the course of the experiment the human subject should be at liberty to bring the experiment to an end
Ten
During the course of the experiment the scientist in charge must be prepared to terminate the experiment at any stage,
that continuation of the experiment is likely to result in injury, disability, or death to the experimental subject.
34.6K
views
159
comments
Serious adverse vaccine events
Dr. Joseph Fraiman, Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults
Paper in Vaccine, 31 August 2022.
https://pubmed.ncbi.nlm.nih.gov/36055877/
What stimulated you to carry out this research in the first place, what got you interested in the topic?
You refer to the Brighton Collaboration, what is this and how did this feed in to your thinking?
Brighton Collaboration identified adverse events of special interest following covid vaccinations, what adverse events were identified?
You conducted a secondary analysis of the placebo-controlled, phase III randomized clinical trials of Pfizer and Moderna mRNA COVID-19 vaccines in adults.
Tell us a bit about these trials, is this sort of trial standard in testing new pharmaceuticals?
What is a secondary analysis?
What do you mean by excess risk?
What excess risk did you discover?
Pfizer vaccines excess risk of serious adverse events
10.1 per 10,000
Higher than placebo baseline of 17.6 per 10,000
Is it fair to say that this transposes into one serious adverse event per 990 vaccines?
Moderna vaccines excess risk of serious adverse events
15.1 per 10,000
Higher than placebo baseline of 42.2 per 10,000
Is it fair to say that this transposes into one serious adverse event per 662 vaccines?
Combined RNA covid vaccines excess risk of serious adverse events
12.5 per 10,000
Is it fair to say that this transposes into one serious adverse event per 800 vaccines?
You also gave reanalysis data in terms of risk ratio.
What is risk ratio?
Combined, 1.43
Pfizer trial
Exhibited, 36 % higher risk of serious adverse events in the vaccine group
Risk ratio 1.36
Moderna trial
Exhibited, 6 % higher risk of serious adverse events in the vaccine group
Risk ratio 1.06
Combined
Exhibited, 16 % higher risk of serious adverse events in the vaccine group
Risk ratio 1.16
These risks of harm sound high to me, how does this level of risk compare to other vaccines and treatments?
You suggest a formal harm-benefit analyses, what is this and how would this be done?
What are participant level datasets, are these important.
Did you have access to participant level datasets
The original vaccine papers indicated high levels of efficacy in protecting against infection.
What is the difference between relative and absolute risk?
Were these results presented as relative or absolute risk of infection?
Would it have been useful if the original vaccine trial papers had presented absolute risk as well as relative risk?
FDA
Now using near real time surveillance for vaccine safety.
Is this near real time claim working, are we getting timely data?
Is there a risk of false positives in the FDA data collection, or are false negatives an issue?
Can the FDA safely ignore AESIs that are of minimal clinical significance?
Is the FDA methodology confirming previously known AESIs, or is it missing some?
From where is the FDA collecting data and are the data from all sources pooled to improve the power of the analysis?
Is all data being collected from all 50 States?
Is all FDA data open to independent peer review?
30.8K
views
108
comments